Access cutting-edge uveal melanoma treatment through this clinical trial at a research site in Chicago. Study-provided care at no cost to qualified participants.
Access uveal melanoma specialists in Chicago at no cost
This study follows strict safety protocols and ethical guidelines
All study-related uveal melanoma treatment provided free
The goal of this clinical research study is to find out if Cemiplimab plus Ziv-Aflibercept is safe and effective in treating your condition of metastatic (spread to other parts of your body) uveal melanoma. This research study will test the study drugs to see if the combination of Cemiplimab plus Ziv-Aflibercept can make tumors shrink or stop growing.
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Check if you qualify for this uveal melanoma clinical trial in Chicago, IL
If you're searching for uveal melanoma treatment options in Chicago, IL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Chicago research site is actively enrolling participants for this clinical trial. You'll receive care from experienced uveal melanoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.